Alembic Pharmaceuticals gets USFDA nod for generic eye infection treatment suspension
Published on: Dec. 11, 2025, 3:16 p.m. | Source: Daily Excelsior
NEW DELHI, Dec 11: Alembic Pharmaceuticals Ltd on Thursday said it has received final approval from the US health regulator for its generic version of Loteprednol Etabonate and Tobramycin ophthalmic suspension used for treatment of eye infection. The approval granted by the US Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Loteprednol Etabonate and Tobramycin Ophthalmic Suspension of strength 0.5 per cent/0.3 per cent (5 mL and 10 mL), Alembic Pharmaceuticals Ltd said in a […]
